Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity

Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity

Abstract The role of the bone marrow (BM) microenvironment in regulating the antitumor immune response in Waldenstrom macroglobulinemia (WM) remains poorly understood. Here we transcriptionally and phenotypically profiled non-malignant (CD19- CD138-) BM cells from WM patients with a focus on myeloid...

Full description

Saved in:

Bibliographic Details
Main Authors:	Vaishali Bhardwaj, Zhi-Zhang Yang, Shahrzad Jalali, Jose C. Villasboas, Rekha Mudappathi, Junwen Wang, Prithviraj Mukherjee, Jonas Paludo, Xinyi Tang, Hyo Jin Kim, Jordan E. Krull, Kerstin Wenzl, Anne J. Novak, Patrizia Mondello, Stephen M. Ansell
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-12-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-024-01173-w
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
by: Maddalena Mazzucchelli, et al.
Published: (2018-01-01)

CNS Vasculitis Associated with Waldenström Macroglobulinemia
by: Tanawan Riangwiwat, et al.
Published: (2016-01-01)

Focal Segmental Glomerulosclerosis in Waldenström’s Macroglobulinemia
by: Akshee Batra, et al.
Published: (2020-01-01)

Waldenström Macroglobulinemia and Cerebral Venous Thrombosis: From Diagnosis to Complication
by: Paulo Zoé Costa, et al.
Published: (2019-01-01)

Systemic Amyloidosis and Cardiac Autonomic Neuropathy Associated with Waldenstrom’s Macroglobulinemia
by: Aasems Jacob, et al.
Published: (2017-01-01)

A Diagnostic Dilemma: Waldenström's Macroglobulinemia/Plasma Cell Leukemia
by: Bhawna Sethi, et al.
Published: (2012-01-01)

Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
by: Simon Østergaard, et al.
Published: (2024-12-01)

Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature
by: Ryan Nipp, et al.
Published: (2014-01-01)

HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia
by: Mark R. Wallace
Published: (2020-01-01)

As a Cause of Fever Unknown Origin, Waldenstrom's Macroglobulinemia: a Case Report
by: mehmet ozen, et al.
Published: (2014-08-01)

Optimal use of BTK inhibitors in Waldenström’s macroglobulinemia: combination or single drug approach?
by: Eirini Solia, et al.
Published: (2024-12-01)

Multimodal Imaging of Waldenstrom Macroglobulinemia-Associated Hyperviscosity-Related Retinopathy Treated with Plasmapheresis
by: Michael J. Schatz, et al.
Published: (2021-01-01)

Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature
by: Riccardo Paggi, et al.
Published: (2023-04-01)

Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment
by: Karima Amaador, et al.
Published: (2023-02-01)

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
by: Benjamin M. Heyman, et al.
Published: (2025-02-01)

20035. SÍNDROME DE BING-NEEL, COMPLICACIÓN NEUROLÓGICA DE LA MACROGLOBULINEMIA DE WALDENSTRÖM
by: N. Peláez Viña, et al.
Published: (2024-11-01)

Waldenstrom’s Macroglobulinemia: A Report of Two Cases, One with Severe Retinopathy and One with Renal Failure
by: Naoko Kudo, et al.
Published: (2017-01-01)

Utility of Bruton’s Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström’s Macroglobulinemia)
by: Maroun Bou Zerdan, et al.
Published: (2022-01-01)

Mismatches in optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study
by: Sunny Chi Lik Au
Published: (2024-12-01)

CORRIGENDUM: Optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study
by: Gilda Cennamo, et al.
Published: (2024-12-01)

WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS
by: Michele Bibas, et al.
Published: (2024-06-01)

Immunosenescence of Polymorphonuclear Neutrophils
by: Inga Wessels, et al.
Published: (2010-01-01)

Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom’s Macroglobulinemia
by: D. Kazmierski, et al.
Published: (2017-01-01)

Polymorphonuclear myeloid-derived suppressor cells regulates immune recovery during HIV infection through PD-L1 and TGF-β pathways
by: Zihua Wang, et al.
Published: (2024-12-01)

Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
by: Alessandra Trojani, et al.
Published: (2024-12-01)

Targeting Polymorphonuclear Leukocytes in Acute Myocardial Infarction
by: Clara Di Filippo, et al.
Published: (2007-01-01)

Different Modulating Effects of Adenosine on Neonatal and Adult Polymorphonuclear Leukocytes
by: Pei-Chen Hou, et al.
Published: (2012-01-01)

Polymorphonuclear Leukocytes or Hydrogen Peroxide Enhance Biofilm Development of Mucoid Pseudomonas aeruginosa
by: Qi Tan, et al.
Published: (2018-01-01)

Investigation of effects chloramphenicol on bovine polymorphonuclear leucocytes (pmnl) functions in vitro and in vivo
by: Ahmet Levent Baş, et al.

Transepithelial Migration Process Induced by Interleukin-8 Delays Polymorphonuclear Leukocytes (PMNL) Apoptosis
by: Gaëlle Le'Negrate, et al.
Published: (2001-01-01)

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
by: Francesca Ricci, et al.
Published: (2011-07-01)

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
by: Alessandra Tedeschi, et al.
Published: (2011-01-01)

Heparin Interaction with the Primed Polymorphonuclear Leukocyte CD11b Induces Apoptosis and Prevents Cell Activation
by: Meital Cohen-Mazor, et al.
Published: (2015-01-01)

Abnormal directed migration of blood polymorphonuclear leukocytes in rheumatoid arthritis. Potential role in increased susceptibility to bacterial infections
by: F. Aglas, et al.
Published: (1998-01-01)

Two Cases of Macroglobulinemia with Elevated Serum CA125: Case Reports and Literature Review
by: Zhao H, et al.
Published: (2024-12-01)

EVALUATION OF POLYMORPHONUCLEAR IMMUNE CELLS IN BIOCOMPATIBILITY TEST DFLP SPONGE CARTILAGE SCAFFOLD, ADIPOSE-DERIVED MSC AND SECRETOME WITH CARTILAGE INJECTION MODEL
by: Brilliant Citra Wirashada, et al.
Published: (2020-04-01)

Inhibitory effect of LY 255283 on the synthesis of leukotriene B4 and thromboxane A2 in human peripheral blood polymorphonuclear leukocytes and monocytes
by: M. Ugur, et al.
Published: (1993-01-01)

Molecular Pathogenesis of MALT Lymphoma
by: Katharina Troppan, et al.
Published: (2015-01-01)

Oncogene-tumor suppressor gene feedback interactions and their control
by: Baltazar D. Aguda, et al.
Published: (2015-07-01)

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
by: K. C. Masoumi, et al.
Published: (2011-01-01)